Advanced Medicine

Our latest eBook gives a snapshot of innovation in cell and gene therapies

We had the pleasure of video interviewing Vered Caplan, CEO of Orgenesis, at the latest ISCT convention in Paris (2023).

Check out our latest video interview with Angela Osborne who discusses the latest cell and gene industry trends.

Sitting Down With… Theresa Heah, CEO, Intergalactic Therapeutics, Cambridge, Massachusetts

A selection of experts using genome editing and CRISPR/Cas9 for drug development purposes offer their views on the field.

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

Sitting Down With… Sheila Mikhail, CEO and co-founder, AskBio; founder, Columbus Children’s Foundation.

Is safeguard sgRNA the key to reducing the off-target effects of gene editing, while increasing its potential applications?

Why automated synthetic biology solutions can pave the way forward for both TCR-T and CAR-T research.

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.